FDA issued a Warning Letter to Promed Exports Private Limited on 8/9/2013 for a previous inspection.
483 Sentiss Pharma Jul 2014

483 Sentiss Pharma Jul 2014

Justin Boyd FDA, Christophe Peters FDA$119.00 - Available Now

FDA investigators audited the Sentiss Pharma - District Solan, India facility and issued inspectional observations (via FDA 483) on 29 Jul 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jul 2014
  • Location: District Solan, India
  • FEI: 3008250236
Add To Cart